000 01224 a2200361 4500
005 20250514043248.0
264 0 _c20030711
008 200307s 0 0 eng d
022 _a0958-7578
024 7 _a10.1046/j.1365-3148.2002.00383.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoth, W K
245 0 0 _aThe German experience with NAT.
_h[electronic resource]
260 _bTransfusion medicine (Oxford, England)
_cAug 2002
300 _a255-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBlood Banks
_xstandards
650 0 4 _aBlood Donors
650 0 4 _aDNA, Viral
_xblood
650 0 4 _aGermany
650 0 4 _aHIV-1
_xgenetics
650 0 4 _aHepacivirus
_xgenetics
650 0 4 _aHepatitis B virus
_xgenetics
650 0 4 _aHumans
650 0 4 _aInfection Control
_xmethods
650 0 4 _aMass Screening
_xmethods
650 0 4 _aNucleic Acid Amplification Techniques
_xmethods
650 0 4 _aRNA, Viral
_xblood
650 0 4 _aBlood Banking
_xmethods
700 1 _aSeifried, E
773 0 _tTransfusion medicine (Oxford, England)
_gvol. 12
_gno. 4
_gp. 255-8
856 4 0 _uhttps://doi.org/10.1046/j.1365-3148.2002.00383.x
_zAvailable from publisher's website
999 _c12100695
_d12100695